Literature DB >> 9753263

Cisapride enhances the effect of partial posterior fundoplication on esophageal peristalsis in GERD patients with poor esophageal contractility.

G J Wetscher1, K Glaser, T Wieschemeyer, M Gadenstätter, P Klingler, A Klingler, R A Hinder.   

Abstract

Partial posterior fundoplication improves esophageal peristalsis in patients with gastroesophageal reflux disease (GERD) associated with poor esophageal body function. The aim of this study was to investigate whether postoperative administration of cisapride enhances the effect of surgery on esophageal peristalsis. Laparoscopic partial posterior fundoplication was performed on 34 consecutive GERD patients with poor esophageal body motility. These patients were randomized in groups without and with postoperative treatment with cisapride 20 mg twice daily for six months. Esophageal manometry was performed preoperatively and six months following surgery. Esophageal body function improved significantly following partial posterior fundoplication without or with postoperative treatment with cisapride. However, this effect was more pronounced in the group of patients receiving cisapride. Partial posterior fundoplication combined with postoperative treatment with cisapride should be the therapy of choice in GERD patients with poor esophageal body motility.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753263     DOI: 10.1023/a:1018890727053

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Effect of Nissen fundoplication on esophageal motor function.

Authors:  H J Stein; R M Bremner; J Jamieson; T R DeMeester
Journal:  Arch Surg       Date:  1992-07

2.  Circadian esophageal motor function in patients with gastroesophageal reflux disease.

Authors:  H J Stein; E P Eypasch; T R DeMeester; T C Smyrk; S E Attwood
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

3.  Does healing of esophagitis improve esophageal motor function?

Authors:  V F Eckardt
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

4.  Tailored antireflux surgery for gastroesophageal reflux disease: effectiveness and risk of postoperative dysphagia.

Authors:  G J Wetscher; K Glaser; T Wieschemeyer; M Gadenstaetter; R Prommegger; C Profanter
Journal:  World J Surg       Date:  1997 Jul-Aug       Impact factor: 3.352

5.  Laparoscopic Toupet fundoplication for gastroesophageal reflux disease with poor esophageal body motility.

Authors:  R J Lund; G J Wetcher; F Raiser; K Glaser; G Perdikis; M Gadenstätter; N Katada; C J Filipi; R A Hinder
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

6.  Successful management of severe gastroesophageal reflux disease with laparoscopic Nissen fundoplication.

Authors:  D E Pitcher; M J Curet; D T Martin; R R Castillo; P D Gerstenberger; D Vogt; K A Zucker
Journal:  Am J Surg       Date:  1994-12       Impact factor: 2.565

7.  Laparoscopic Nissen fundoplication: operative results and short-term follow-up.

Authors:  H B Bittner; W C Meyers; S R Brazer; T N Pappas
Journal:  Am J Surg       Date:  1994-01       Impact factor: 2.565

8.  Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists.

Authors:  A L Blum; B Adami; M H Bouzo; G Brandstätter; I Fumagalli; J P Galmiche; H Hebbeln; E Hentschel; W Hüttemann; E SChütz
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

9.  Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH.

Authors:  M Wienbeck; Q Li
Journal:  Scand J Gastroenterol Suppl       Date:  1989

10.  Effect of cisapride on postprandial gastro-oesophageal reflux.

Authors:  R H Holloway; J Downton; B Mitchell; J Dent
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

View more
  1 in total

1.  Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease.

Authors:  G J Wetscher; M Gadenstaetter; P J Klingler; H Weiss; P Obrist; H Wykypiel; A Klaus; C Profanter
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.